NP49425 Generic and Biosimilar Transition Medicines

Supply of generic cand biosimilar transition medicines to NHS Scotland. The Authority has awarded this Lot as an unranked multi supplier Framework Agreement per line to six (6) Framework Participants. Full details of Goods and volumes can be found within the ITT (Invitation to Tender) documents.

Supply of cytokine modulators (omalizumab) to NHS Scotland. The Authority has awarded this Lot as an unranked multi supplier Framework Agreement per product line.

Supply of gastrointestinal, endocrine, blood, and multiple sclerosis medicines to NHS Scotland. The Authority has awarded this Lot as a ranked multi supplier Framework Agreement per product line.

Supply of denosumab (osteoporosis) and ferric carboxymaltose to NHS Scotland. The Authority has awarded this Lot as an unranked multi supplier Framework Agreement per product line.

Supply of apremilast to NHS Scotland. The Authority has awarded this Lot as a ranked multi supplier Framework Agreement per product line.

Supply of cardiovascular and respiratory medicines to NHS Scotland. The Authority has awarded this Lot as a ranked multi supplier Framework Agreement per product line.

Supply of nintedanib to NHS Scotland. The Authority has awarded this Lot as a ranked multi supplier Framework Agreement per product line.

Supply of cancer medicines (group 1) to NHS Scotland. The Authority has awarded this Lot as a ranked multi supplier Framework Agreement per product line.

Supply of cancer medicines (group 2) to NHS Scotland. The Authority has awarded this Lot as an unranked multi supplier Framework Agreement per product line.

Supply of psychiatry and neurology medicines to NHS Scotland. The Authority has awarded this Lot as a ranked multi supplier Framework Agreement per product line.